DudeDiligence.

CorMedix Inc

CRMDNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$2,273,378

6 notices · 207,000 sh

Reported ·

$2,300,156

7 sales · 1 buy · $391,200 bought

5 of 7 reported sales carry the 10b5-1 box. Together they are 0.26% of the shares on issue.

PLANNED · FORM 144REPORTED · FORM 4D2025J2026FMAMJJASON2026-01-21: Janet Dillione, Form 1442025-12-30: Alan Dunton, Form 1442025-12-18: Joseph Todisco, Form 1442025-12-09: Lefkowitz Steven W, Form 1442025-12-09: Janet Dillione, Form 1442025-11-24: Janet Dillione, Form 1442025-11-24: Dillione Janet, sold2025-12-02: Dillione Janet, sold2025-12-09: Lefkowitz Steven W, sold2025-12-09: Dillione Janet, sold2025-12-18: Todisco Joseph, sold2025-12-30: DUNTON ALAN W, sold2026-01-21: Dillione Janet, sold2026-11-13: Todisco Joseph, bought
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

Jan 21Janet Dillione, Director$68,502
10,000 shplan Aug 25, 2025144 ↗
Form 4, Jan 22: sold 10,000 at $6.88This transaction was executed in multiple trades at prices ranging from $6.85 to $6.90, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff... Form 4 ↗
Dec 30, 2025Alan Dunton, Director$259,400
20,000 shplan Aug 19, 2025144 ↗
Form 4, Jan 2: sold 20,000 at $13.00 Form 4 ↗
Dec 18, 2025Joseph Todisco, Chief Executive Officer$359,149
30,000 shplan Sep 11, 2025144 ↗
Form 4, Dec 19, 2025: sold 30,000 at $12.00This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC... Form 4 ↗
Dec 9, 2025Lefkowitz Steven W, Director$450,400
40,000 shno plan date144 ↗
Form 4, Dec 10, 2025: sold 40,000 at $11.88This transaction was executed in multiple trades at prices ranging from $11.87 to $11.92, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC... Form 4 ↗
Dec 9, 2025Janet Dillione, BOD$408,000
34,000 shplan Aug 25, 2025144 ↗
Form 4, Dec 11, 2025: sold 34,000 at $12.00This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC... Form 4 ↗
Nov 24, 2025Janet Dillione, Director$727,927
73,000 shplan Aug 25, 2025144 ↗
Form 4, Nov 26, 2025: sold 26,343 at $9.93This transaction was executed in multiple trades at prices ranging from $9.72 to $10.00, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC... Form 4 ↗